Roche extends Illumina offer until late April

ZURICH, March 26 (Reuters) - Swiss drugmaker Roche Holding
AG extended its $5.7 billion cash bid once again for
U.S. gene decoder Illumina on Monday, as Roche sticks
to its tried and tested M&A strategy.

mobile application development companies in usa software application development companies app developers london